Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Levodopa News Monitoring

Get by Email • RSS

Published on Nov 2, 2026

Safety-First, Severity-Adapted Enhanced Recovery After Surgery for Patients with Neurodegenerative Disorders: A ...

Introduction Enhanced Recovery After Surgery (ERAS) has been widely implemented in hospitals worldwide over the past 30 years and has consistently demonstrated reductions in complication rates, shorter length of hospitalization, and optimized resource …

Source: Dove Medical Press - Neutral
Published on Oct 30, 2026

Incisionless brain procedure eliminates Parkinson's tremors for air force veteran

To the untrained eye, a "ham" radio may look like a simple device. However, inside its casing, dozens of delicate wires and tiny elements perform distinct yet connected functions to deliver messages to a vast network of operators around the world …

Source: Medical News - Neutral
Published on Oct 29, 2026

Buzzy longevity supplement flops in major Parkinson’s trial — it actually worsened symptoms

This theory didn’t age well. A popular supplement commonly marketed for improving longevity failed to show meaningful benefits for people with early-stage Parkinson’s disease in a new study. The findings dash hopes that the vitamin B3 derivative could slow …

Source: New York Post - Right-wing
Published on Oct 28, 2026

Rams Legend Lawrence McCutcheon Dies at 76 After Long Parkinson's Battle as Family Asks Fans to Support Research

Lawrence McCutcheon, the five-time Pro Bowl running back who spent more than four decades with the Rams as a player and front-office executive, died Oct. 23 at age 76. His family said he died after "a long, courageous battle with Parkinson's …

Source: Medical Daily - Indeterminate
Published on Oct 30, 2026

Aspen raises a $141M IPO in pursuit of a cell therapy for Parkinson’s

Parkinson’s cell therapy developer Aspen Neuroscience on Thursday evening its initial public offering, raising $140.6 million to take its treatment deeper into clinical testing. Aspen sold roughly 9.4 million shares at $15 each, on the low end of the price …

Source: BioPharma Dive - Pending
Published on Oct 30, 2026

Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’

While biologic drugs have been a boon to immunology, many of them are monoclonal antibodies able to address only individual targets. Multiple pathways are typically involved in inflammation, so blocking one leaves others open to continue driving disease. …

Source: MedCity News - Neutral
Published on Oct 27, 2026

Healthy Aging Supplement Fails in Large PD Trial

Nicotinamide riboside (NR), a supplement promoted for healthy aging, did not slow the progression of early Parkinson’s disease (PD) in a new phase 3 trial. A derivative of vitamin B3, NR boosts levels of nicotinamide adenine dinucleotide (NAD+), a molecule …

Source: Medscape - Neutral
Published on Oct 25, 2026

Marshall Faulk Says a Stiff Hand After Golf Was His First Parkinson's Sign, Urging People Not to Wait

Pro Football Hall of Famer Marshall Faulk says the first sign of his Parkinson's disease was not a tremor. It was a stiff hand on the golf course. The 53-year-old Southern University head coach disclosed his diagnosis in a podcast interview released …

Source: Medical Daily - Indeterminate
Published on Oct 29, 2026

How a new brain procedure gave Parkinson’s tremor patient back the hobby he loves

To the untrained eye, a “ham” radio may look like a simple device. However, inside its casing, dozens of delicate wires and tiny elements perform distinct yet connected functions to deliver messages to a vast network of operators around the world. …

Source: Newswise - Neutral
Published on Oct 30, 2026

Aspen raises a $141M IPO in pursuit of a cell therapy for Parkinson’s

Parkinson’s cell therapy developer Aspen Neuroscience on Thursday evening its initial public offering, raising $140.6 million to take its treatment deeper into clinical testing. Aspen sold roughly 9.4 million shares at $15 each, on the low end of the price …

Source: BioPharma Dive - Pending
Published on Oct 23, 2026

I thought I was just clumsy... but it was an early warning sign of Parkinson's at 37: As cases of the devastating ...

It was via a letter, slipped through the door on her 37th birthday, that Emma Karembo Cornthwaite first learnt of the diagnosis which would change her life. Adventurous and a lover of the outdoors, Emma had spent years leading expedition groups, travelling …

Source: Daily Mail - Right-wing
Published on Oct 20, 2026

Laxxon Medical to Participate in the Jefferies Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Oct 20, 2026-- Laxxon Medical Corp. (“Laxxon Medical” or the “Company”), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID ® (Screen Printed Innovative Drugs) technology …

Source: Voice of Alexandria - Minnesota - Indeterminate
Published on Oct 27, 2026

Not Your Mother’s Dopamine Agonist: Tavapadon

This transcript has been edited for clarity. Kathrin LaFaver, MD: Hi, and welcome on behalf of Medscape. My name is Dr Kathrin LaFaver. I'm a neurologist and Parkinson's specialist in Saratoga Springs, New York. I have the great pleasure today of …

Source: Medscape - Neutral
Published on Oct 18, 2026

Doctors tell man his mom is hours from death. Then he tries something unconventional to save her: ‘Felt like a House ...

A man saved his dying mom by using artificial intelligence to identify a rare vitamin deficiency. The AI tool suggested an unconventional treatment that stopped her severe seizures within minutes. According to PEOPLE, Edward Patrick, an anesthetist from …

Source: The Mary Sue - Center-left
Published on Oct 16, 2026

FDA approves Parkinson’s drug based on University of Virginia research

The Food and Drug Administration has approved a new Parkinson’s disease drug based on research by University of Virginia scientists that could help patients control symptoms with a once-daily pill, UVA Health announced last week. Tavapadon, sold under the …

Source: InsideNoVa - Virginia - Neutral
Published on Oct 13, 2026

FDA approves new Parkinson’s drug pioneered by UVA scientists

The federal Food and Drug Administration has approved a new Parkinson's disease drug that was based on research by UVA Health scientists. The drug tavapadon, now branded Juvmo, was pioneered by University of Virginia School of Medicine Professor of …

Source: Medical News - Neutral
Published on Oct 18, 2026

Progressive supranuclear palsy: this rare neurological disease is often confused with Parkinson's

Unexplained falls, difficulty looking down, or unusual stiffness: these symptoms can indicate progressive supranuclear palsy, a rare neurodegenerative disease sometimes confused with Parkinson's disease. Its diagnosis remains complex, particularly …

Source: Entrevue - Indeterminate
Published on Oct 8, 2026

Daily pill for Parkinson's disease raises hopes patients could see first major new class of treatment in decades

A daily pill for Parkinson's disease has demonstrated huge benefits in a late–stage trial, raising hopes patients could see the first major new class of treatment in decades. The drug significantly reduced the amount of time patients spent struggling …

Source: Daily Mail - Right-wing
Published on Oct 7, 2026

Daily pill raises hopes for new generation of Parkinson’s drugs

A new daily pill could help people with Parkinson's disease live more of their life without symptoms, a trial has found. The drug, called solengepras, successfully reduced how much of the day patients struggled with movement issues, raising hopes of a …

Source: Yahoo News - United Kingdom - Center-left

06 days 21:50:22

Featured Releases

Got News to Share? · Submit · See All

Published on November 2, 2026 - 13:15 GMT

Pharmacies Rethink the Workflow: Conveyor Systems Emerge as the Backbone of Modern Pharmaceutical Handling

Rising prescription volumes and chronic-care demand are driving pharmacies toward lean, ergonomic, conveyor-assisted fulfillment. WESTPORT, MA, UNITED STATES, November 2, 2026 /⁨EINPresswire.com⁩/ -- As more Americans rely on daily medications and …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on November 3, 2026 - 02:59 GMT

Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement

-- Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon and RM-718 -- -- Rhythm to pay LG Chem additional fixed payments totaling $350 million over four …

Distribution channels:

Published on November 2, 2026 - 14:00 GMT

Aesthetic Record and BoomRX Integrate to Simplify Medication Access for Aesthetic and Wellness Practices

The integration connects Aesthetic Record practices with a pharmaceutical technology platform, streamlining access to pharmacies, products, and fulfillment. IRVING, TX, UNITED STATES, November 2, 2026 /⁨EINPresswire.com⁩/ -- Aesthetic Record, the …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on November 2, 2026 - 22:00 GMT

Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026

Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of …

Distribution channels:

Published on November 2, 2026 - 16:56 GMT

Eyam Health Announces Research Evaluation of Its Gemini saRNA Platform with Astellas

Eyam's Gemini platform is being evaluated by Astellas, a global pharmaceutical leader, for its potential to support durable expression of therapeutic proteins. VANCOUVER, BC, CANADA, November 2, 2026 /⁨EINPresswire.com⁩/ -- Eyam Health today …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on November 2, 2026 - 22:00 GMT

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment …

Distribution channels:
Published on November 3, 2026 - 05:53 GMT

Historical Toxicology Data Can Inform Future Drug Safety Studies, New Analysis Suggests

Analysis of more than 800 drugs identifies recurring toxicity patterns that could inform preclinical study design and help reduce unnecessary animal testing. DURHAM, NC, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- The pharmaceutical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 2, 2026 - 21:30 GMT

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-...

New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in larger, higher-risk polyps. REC-4881 shows deep activity …

Distribution channels:

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 954,078,530 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 10/10/2026

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on November 3, 2026 - 05:53 GMT

Keep Safe Care Expands into Houston, Names Jeff Foteh Territory Developer

Caregiver-first home care company expands its efficient operating model with higher caregiver wages and lower caregiver turnover to Houston HOUSTON, TN, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- Keep Safe Care, a rapidly expanding …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on November 3, 2026 - 05:53 GMT

Historical Toxicology Data Can Inform Future Drug Safety Studies, New Analysis Suggests

Analysis of more than 800 drugs identifies recurring toxicity patterns that could inform preclinical study design and help reduce unnecessary animal testing. DURHAM, NC, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- The pharmaceutical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 3, 2026 - 05:53 GMT

Sedation Dentistry for Children in Tribeca, Matched to the Child — Not the Other Way Around

Tribeca Dental Studio's pediatric team offers laughing gas and full sedation options for anxious, very young, and special-needs children. NEW YORK, NY, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- For many children, the barrier to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 3, 2026 - 05:51 GMT

SNU Eye Clinic Builds on Global Experience in Next-Generation SMILE Surgery

SNU Eye Clinic combines global SMILE research experience with advanced SMILE Pro technology and personalized vision correction. SEOUL, SOUTH KOREA, November 3, 2026 /⁨EINPresswire.com⁩/ -- SNU Eye Clinic in South Korea is strengthening its personalized …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on November 3, 2026 - 05:27 GMT

Digifab Market Report Details Major Competitors, Key Segments, and Regional Trends

The Business Research Company’s Digifab Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Digifab market is gaining significant attention as …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Draximage MAA Market Report Analyzes Market Trends, Segment Details, and Business Strategies

The Business Research Company’s Draximage MAA Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Draximage MAA market is gaining attention …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Breakthroughs in Autoimmune Disease Drug Discovery: Cloud-Clone’s End-to-End Toolkit from Molecules to Animal Models

Overcoming Heterogeneity-Driven Bottlenecks to Accelerate Novel Therapeutic Development HUSTON, TX, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- Systemic autoimmune diseases (SAIDs) represent a major unmet medical challenge worldwide. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...
Published on November 3, 2026 - 05:27 GMT

Decoding Functional Profiles of Bio-Active Proteins: From Basic Concepts to Activity Assays

HUSTON, TX, UNITED STATES, November 3, 2026 /⁨EINPresswire.com⁩/ -- Merely confirming protein presence is insufficient; biological activity defines functional performance. A protein may remain chemically detectable yet lose its biological function once its …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...
Published on November 3, 2026 - 05:27 GMT

Analysis of Dupixent Market Segmentation Highlights Significant Growth Opportunities Through 2030

The Business Research Company’s Analysis of Dupixent Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Dupixent market is gaining …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Dengvaxia Market Forecast to 2030: Size, Growth Rate, Trends, and Analysis

The Business Research Company’s Dengvaxia Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Dengvaxia vaccine market is witnessing …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Competitive Landscape of the Dukoral Market Examined Among Top Global Companies

The Business Research Company’s Competitive Landscape of the Dukoral Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- Understanding the …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

The Global Digibind Market Is Experiencing Rapid Growth-Latest Research by The Business Research Company

The Business Research Company’s The Global Digibind Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Digibind market is set to experience …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Ducord Market Industry Outlook Improves as Global Demand Increases

The Business Research Company’s Ducord Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Ducord market is positioned for significant …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Recent Egrifta (Tesamorelin Acetate) Market Analysis ,Emphasizing Upcoming Industry Trends and Projections

The Business Research Company’s Recent Egrifta (Tesamorelin Acetate) Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- Understanding the …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Ebanga Market Research Report Providing Analysis on Growth, Segmentation, and Key Competitors

The Business Research Company’s Ebanga Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Ebanga market is gaining significant attention due …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Detailed Daratumumab and Darzalex Market Report Includes Forecasts, Innovations, and Industry Insights

The Business Research Company’s Detailed Daratumumab and Darzalex Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The market for daratumumab, …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Darzalex Faspro Market Analysis Report Examining Demand Patterns and Competitive Landscape

The Business Research Company’s Darzalex Faspro Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Darzalex Faspro market is gaining …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Daxxify (DaxibotulinumtoxinA) Market Outlook Report Including Segment Analysis and Strategic Industry Insights

The Business Research Company’s Daxxify (DaxibotulinumtoxinA) Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- Exploring the expanding …

Distribution channels: Business & Economy, Chemical Industry ...
Published on November 3, 2026 - 05:27 GMT

Trends and Forecast Analysis of the Elase-chloromycetin Market Indicate Significant Long-Term Growth Potential

The Business Research Company’s Elase-chloromycetin Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- The Elase-chloromycetin market is …

Distribution channels: Business & Economy, Companies ...
Published on November 3, 2026 - 05:27 GMT

Detailed Elelyso Market Analysis Includes Projections, Innovations, and Industry Insights

The Business Research Company’s Elelyso Market Analysis Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 3, 2026 /⁨EINPresswire.com⁩/ -- Understanding the Elelyso Market’s …

Distribution channels: Business & Economy, Companies ...